FAQ: Nutriband Inc.'s Inclusion in Russell Indexes and Its AVERSA Technology
Summary
Nutriband Inc. (NASDAQ: NTRB) has been added to four Russell indexes in 2025, highlighting market recognition of its AVERSA technology, particularly for the AVERSA Fentanyl patch, which has significant sales potential.
What is Nutriband Inc. known for?
Nutriband Inc. is primarily engaged in the development of transdermal pharmaceutical products, notably its AVERSA(TM) abuse-deterrent technology designed to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.
Why was Nutriband Inc. added to the Russell indexes?
Nutriband Inc. was added to the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes as part of the 2025 Russell indexes reconstitution, reflecting market recognition and momentum behind its AVERSA pipeline.
What is the significance of Nutriband’s inclusion in the Russell indexes?
Inclusion in the Russell indexes, which benchmark approximately $10.6 trillion in assets, signifies growing market recognition and can enhance visibility among investment managers and institutions.
What is AVERSA Fentanyl, and what is its potential?
AVERSA Fentanyl is Nutriband’s lead product under development, an abuse-deterrent fentanyl patch incorporating AVERSA technology, with potential peak annual U.S. sales between $80 million and $200 million.
How can I learn more about Nutriband Inc.?
For more information about Nutriband Inc., visit their website at www.Nutriband.com or check the latest news and updates at https://ibn.fm/NTRB.
What is BioMedWire?
BioMedWire is a specialized communications platform focusing on the latest developments in the Biotechnology, Biomedical Sciences, and Life Sciences sectors, part of the Dynamic Brand Portfolio @ IBN, offering extensive distribution and corporate communications solutions.
How can I receive alerts from BioMedWire?
To receive SMS alerts from BioMedWire, text ‘Biotech’ to 888-902-4192 (U.S. Mobile Phones Only). For more information, visit https://www.biomedwire.com/.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)
Article Control ID: 99480